tranexamic acid has been researched along with dalteparin in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 9 (81.82) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Asero, R; Cugno, M; Tedeschi, A | 1 |
DeSimone, LJ; Gillette, BP; Pagnano, MW; Sierra, RJ; Trousdale, RT | 1 |
Tkachenko, AI | 1 |
Campbell, JC; Mirocha, JM; Sharfman, ZT; Spitzer, AI | 1 |
Bautista, MP; Bonilla, GA; Gutierrez, C; Llinas, AM; Monsalvo, DJ | 1 |
Campbell, JC; Sharfman, ZT; Spitzer, AI | 1 |
Hu, KZ; Sui, C; Sun, HY | 1 |
Huang, Q; Ma, J; Pei, F; Xie, J; Yue, C | 1 |
Duggan, J; Duncan, S; Fraval, A; Murray, T; Tirosh, O; Tran, P | 1 |
Deng, ZF; Fu, M; He, AS; Kang, Y; Liao, WM; Sheng, PY; Xu, DL; Zhang, ZJ | 1 |
Wang, CC; Wu, T; Zhang, GQ; Zhang, LT; Zhou, LB | 1 |
4 trial(s) available for tranexamic acid and dalteparin
Article | Year |
---|---|
Effects of five treatment regimens on blood loss and blood transfusion in total knee arthroplasty: a preliminary study in China
.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Blood Loss, Surgical; Blood Transfusion; China; Factor Xa Inhibitors; Female; Hemoglobins; Humans; Male; Middle Aged; Nadroparin; Patient Positioning; Postoperative Hemorrhage; Rivaroxaban; Time Factors; Tourniquets; Tranexamic Acid; Treatment Outcome | 2017 |
Comparison of Enoxaparin and Rivaroxaban in Balance of Anti-Fibrinolysis and Anticoagulation Following Primary Total Knee Replacement: A Pilot Study.
Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Knee; Blood Coagulation; Drug Interactions; Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Osteoarthritis; Pilot Projects; Postoperative Complications; Prospective Studies; Pulmonary Embolism; Rivaroxaban; Tranexamic Acid; Venous Thromboembolism | 2017 |
OBTAIN E: outcome benefits of tranexamic acid in hip arthroplasty with enoxaparin: a randomised double-blinded controlled trial.
Topics: Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Double-Blind Method; Enoxaparin; Female; Humans; Male; Middle Aged; Postoperative Complications; Tranexamic Acid; Venous Thrombosis | 2019 |
Effectiveness of different antithrombotic agents in combination with tranexamic acid for venous thromboembolism prophylaxis and blood management after total knee replacement: a prospective randomized study.
Topics: Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Dalteparin; Fibrinolytic Agents; Humans; Postoperative Hemorrhage; Prospective Studies; Rivaroxaban; Tranexamic Acid; Venous Thromboembolism | 2023 |
7 other study(ies) available for tranexamic acid and dalteparin
Article | Year |
---|---|
Heparin and tranexamic Acid therapy may be effective in treatment-resistant chronic urticaria with elevated d-dimer: a pilot study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Antifibrinolytic Agents; Cetirizine; Chronic Disease; Disease Progression; Drug Resistance; Female; Fibrin Fibrinogen Degradation Products; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Nadroparin; Pilot Projects; Tranexamic Acid; Treatment Failure; Urticaria; Young Adult | 2010 |
Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty.
Topics: Adult; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Dalteparin; Female; Humans; Male; Retrospective Studies; Risk; Thromboembolism; Tranexamic Acid; Warfarin | 2013 |
[Changes of the hemostasis system in patients with obturation jaundice caused by choledocholithiasis, and possibilities of their correction with the help of miniinvasive operative interventions].
Topics: Anticoagulants; Antifibrinolytic Agents; Blood Coagulation Disorders; Choledocholithiasis; Drug Administration Schedule; Hemostasis; Heparin, Low-Molecular-Weight; Humans; Jaundice, Obstructive; Plasma Exchange; Postoperative Complications; Severity of Illness Index; Sphincterotomy, Endoscopic; Thrombelastography; Tranexamic Acid; Treatment Outcome | 2014 |
Balancing Thromboprophylaxis and Bleeding in Total Joint Arthroplasty: Impact of Eliminating Enoxaparin and Predonation and Implementing Pneumatic Compression and Tranexamic Acid.
Topics: Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Blood Transfusion, Autologous; Cohort Studies; Enoxaparin; Female; Hemorrhage; Humans; Intermittent Pneumatic Compression Devices; Length of Stay; Male; Middle Aged; Thromboembolism; Tranexamic Acid; Venous Thrombosis | 2016 |
Letter to the Editor on "Balancing Thromboprophylaxis and Bleeding in Total Joint Arthroplasty: Impact of Eliminating Enoxaparin and Predonation and Implementing Pneumatic Compression and Tranexamic Acid".
Topics: Anticoagulants; Arthroplasty; Arthroplasty, Replacement, Knee; Enoxaparin; Hemorrhage; Humans; Tranexamic Acid; Venous Thromboembolism | 2016 |
Response to Letter to the Editor on "Balancing Thromboprophylaxis and Bleeding in Total Joint Arthroplasty: Impact of Eliminating Enoxaparin and Predonation and Implementing Pneumatic Compression and Tranexamic Acid".
Topics: Anticoagulants; Arthroplasty; Arthroplasty, Replacement, Knee; Enoxaparin; Hemorrhage; Humans; Tranexamic Acid; Venous Thromboembolism | 2016 |
Effect of 3 different anticoagulants on hidden blood loss during total hip arthroplasty after tranexamic acid.
Topics: Administration, Intravenous; Aged; Anticoagulants; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood Transfusion; China; Enoxaparin; Female; Hemoglobins; Hospitalization; Humans; Length of Stay; Male; Middle Aged; Nadroparin; Occult Blood; Retrospective Studies; Rivaroxaban; Safety; Tranexamic Acid; Treatment Outcome | 2020 |